MedTrace Logo

TESS V3 Modular Total Shoulder System PMCF

NCT05002959 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2025-09-08

No results posted yet for this study

Summary

This is a multicenter, retrospective and prospective, non-controlled post market surveillance study. The objectives of this study are to confirm safety, performance and clinical benefits of the T.E.S.S.® Version 3 Anatomic and Reverse Modular Total shoulder prosthesis and its instrumentation.

Conditions

  • Osteoarthritis Shoulder
  • Rheumatoid Arthritis
  • Rheumatoid Arthritis Shoulder
  • Avascular Necrosis
  • Revision
  • Rotator Cuff Tears
  • Osteonecrosis
  • Rotator Cuff Tear Arthropathy
  • Proximal Humeral Fracture
  • Malunion of Fracture, Shoulder Region

Interventions

DEVICE

Anatomic TESS V3

Implantation of the T.E.S.S.® V3 Modular Total Shoulder System, Anatomic configuration.

DEVICE

Reverse TESS V3

Implantation of the T.E.S.S.® V3 Modular Total Shoulder System, Reverse configuration.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Emilie Rohmer · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2026-10-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05002959 on ClinicalTrials.gov